PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus) |
|
|
| Recruiting | 3 | 3500 | RoW | CAB LA, Apretude, CAB LA for PrEP | ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP | HIV Infections | 06/28 | 06/28 | | |